June 2019 Price Concessions – 1st update


June 2019 Price Concessions – 1st update

June 14, 2019

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:

Drug Pack size Price Concession
Amiloride 5mg tablets 28 £9.49
Betahistine 8mg tablets 84 £2.34
Betahistine 16mg tablets 84 £3.20
Celecoxib 100mg capsules 60 £3.29
Citalopram 40mg/ml oral drops sugar free 15 £9.38
Ibandronic Acid 50mg tablets 28 £55.00
Losartan 12.5mg tablets 28 £3.92
Naproxen 250mg tablets 28 £3.76
Naproxen 250mg gastro-resistant tablets 56 £9.95
Nortriptyline 10mg tablets 100 £4.98
Risedronate sodium 35mg tablets 4 £11.95

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated June 2019 Drug Tariff price. Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.

Posted in: ,

More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...

CPCS: CPD opportunities

As announced in the 5-year CPCF agreement, NHS England & NHS Improvement and Health Education England (HEE) will use funding...